The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
…
continue reading
1
GSK antibiotic hits phase 3 goals, Genentech-Adaptimmune collab ends, Par Pharma recall [The good, the bad, the ugly]
4:10
4:10
나중에 재생
나중에 재생
리스트
좋아요
좋아요
4:10
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — GSK antibiotic hits phase 3 goals in gonorrhea The bad — Genentech ends $3B Adaptimmune T-cell collab The ugly — Par Pharmaceutical recalls Treprostinil injection for potential contamination…
…
continue reading
1
BMS schizophrenia drug shines, Novartis axes jobs, Lilly compounding suit dismissed [The good, the bad, the ugly]
5:01
5:01
나중에 재생
나중에 재생
리스트
좋아요
좋아요
5:01
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — BMS schizophrenia drug shines in phase 3 trial The bad — Novartis to axe 680 jobs The ugly — Lilly compounding suit dismissed저자 Pharma Manufacturing
…
continue reading
Politics, whether we like them or not, weigh heavy on manufacturing’s future. In case you haven’t heard, it is an election year! Which means, global trade, regulations, immigration, national security and taxation will all be part of the national discourse, and all of those topics touch on manufacturing in one way or another. During this podcast, we…
…
continue reading
1
Basilea grabs FDA nod, Verve halts gene editing trial, Amylyx pulls ALS drug [The good, the bad, the ugly]
3:47
3:47
나중에 재생
나중에 재생
리스트
좋아요
좋아요
3:47
Editor's Review: Week of April 1 Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Basilea Pharmaceutica receives FDA approval for its IV antibiotic The bad — Verve Therapeutics halts gene editing trial, again The ugly — Amylyx removes ALS treatment…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of March 25
3:45
3:45
나중에 재생
나중에 재생
리스트
좋아요
좋아요
3:45
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Akebia Therapeutics' Vafseo anemia drug The bad — Bristol Myers Squibb's Crohn's disease drug disappoints The ugly — FDA rejects Regeneron Pharmaceuticals lymphoma treatment…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of March 18
5:31
5:31
나중에 재생
나중에 재생
리스트
좋아요
좋아요
5:31
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Orchard gene therapy wins first FDA nod for rare pediatric disease The bad — Abiomed recalls heart pump instructions due to perforation risks The ugly — J&J files lawsuit against a former employee fo…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of March 11
3:54
3:54
나중에 재생
나중에 재생
리스트
좋아요
좋아요
3:54
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Madrigal wins first FDA nod for NASH The bad — Acadia abandons plans to expand pimavanserin indications The ugly — BIO backs BIOSECURE Act, boots WuXi…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of March 4
4:16
4:16
나중에 재생
나중에 재생
리스트
좋아요
좋아요
4:16
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Boehringer Ingelheim to cap out-of-pocket inhaler prices The bad — Amylyx ALS drug falls short in phase 3 trial The ugly — FDA delays Eli Lilly Alzheimer's drug decision with last-minute AdComm…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of February 29
3:07
3:07
나중에 재생
나중에 재생
리스트
좋아요
좋아요
3:07
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Iovance has launches Amtagvi The bad — FDA rejected Theratechnologies HIV instramuscular injection The ugly — BioMarin receives a subpoena from the DOJ…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of February 23
3:55
3:55
나중에 재생
나중에 재생
리스트
좋아요
좋아요
3:55
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Amtagvi approval The bad — Rapt clinical hold The ugly — Novavax and Gavi settlement저자 Pharma Manufacturing
…
continue reading
Across the board, the pharma industry is facing sky-high pressures to bring drugs to market quickly, safely and affordably. Facing this daunting landscape, pharma companies are enlisting the help of focused contract manufacturers to shape their therapies from the ground up. CDMOs, who so often go unnamed and unsung, have now become integral to forg…
…
continue reading
1
[Solutions Spotlight] Meeting today’s container closure integrity requirements
16:36
16:36
나중에 재생
나중에 재생
리스트
좋아요
좋아요
16:36
In this latest episode of Off Script: A Pharma Manufacturing Podcast, Andrea Corona is joined by Derek Duncan Product Line Director, at Lighthouse Instruments to discuss the significance of CCI and the evolving landscape of CCI testing, regulatory guidance, and the unique considerations posed by innovative therapies with extreme storage and transpo…
…
continue reading
1
[Solutions Spotlight] Ensuring quality during a syringe surge
13:15
13:15
나중에 재생
나중에 재생
리스트
좋아요
좋아요
13:15
In this latest episode of Off Script: A Pharma Manufacturing Podcast, Karen Langhauser is joined by Veronica Ghidotti Product Manager, Visual Inspection Systems at Stevanato Group, to discuss how pharma markets have shifted towards drugs that require syringes and vials — which are historically difficult to inspect — and how new automatic inspection…
…
continue reading
1
[Solutions Spotlight] Overcoming drug formulation challenges
23:43
23:43
나중에 재생
나중에 재생
리스트
좋아요
좋아요
23:43
In this latest episode of Off Script: A Pharma Manufacturing Podcast, Andrea Corona is joined by Daniel Price, director and head of excipients, solid applications at MilliporeSigma, to discuss his work driving innovation in the fields of 3d printing of oral solid dosage forms, next generation pharmaceutical manufacturing, oral delivery of novel mod…
…
continue reading
1
[Solutions Spotlight] Bringing pharma’s asset management into the digital age
25:23
25:23
나중에 재생
나중에 재생
리스트
좋아요
좋아요
25:23
For those in the pharmaceutical industry, the recent challenge has been in figuring out how to extend the digital capability of our everyday lives into pharma asset management. How do you bring all of a plant's activities and the data behind them into one place? Furthermore, if you could do that, what benefits would it bring to asset management? Ka…
…
continue reading
1
[Solutions Spotlight] How to overcome challenges in ophthalmic formulations
14:21
14:21
나중에 재생
나중에 재생
리스트
좋아요
좋아요
14:21
Ophthalmic drug formulation and manufacturing brings with it unique challenges and regulatory requirements. To discuss methods to overcome these challenges, Pharma Manufacturing Senior Editor Andrea Corona speaks with Smita Rajput, field marketing manager at MilliporeSigma. Learn more about MilliporeSigma: https://www.emdmillipore.com/US/en Read th…
…
continue reading
1
[Solutions Spotlight] How digitalization can provide a competitive advantage
15:09
15:09
나중에 재생
나중에 재생
리스트
좋아요
좋아요
15:09
The digitalization journey for pharmaceutical manufacturing can reap many benefits and there are many choices to be made in terms of these technologies and how to deploy them. In this episode, Andrea Corona talks about how digitalization is delivering a competitive advantage and assembly and inspection with Veronica Ghidotti and Fabio Bertacchini f…
…
continue reading
1
[Solutions Spotlight] Stop the stall: The time is now for predictive maintenance in pharma
12:20
12:20
나중에 재생
나중에 재생
리스트
좋아요
좋아요
12:20
Predictive maintenance can help pharma companies can capture enormous value. Digital solutions can help eliminate downtime, reduce maintenance costs and maximize productivity, ultimately unlocking the capacity that is necessary to get the highest quality product to patients who need them most. Senior editor Andrea Corona discusses this with Zach Gi…
…
continue reading
1
[Solutions Spotlight] A groundbreaking approach to BET testing
25:22
25:22
나중에 재생
나중에 재생
리스트
좋아요
좋아요
25:22
Endotoxin testing serves a vital function in pharma quality control by ensuring that products are safe for patients. But the traditional approach to Bacterial Endotoxins Testing (BET) is an area ripe for disruption and improvements. Now, the Sievers Eclipse BET platform by Suez offers new levels of automation, compliance and sustainability, usherin…
…
continue reading
1
[Solutions spotlight] A better way to measure critical attributes in bioreactors
13:17
13:17
나중에 재생
나중에 재생
리스트
좋아요
좋아요
13:17
In pharma, the use of gas analysis in fermentation bioreactors is critical for monitoring the health of a culture, and measuring small changes to oxygen and carbon dioxide concentrations at key phases of the process. Whether using continuous or batch fermentation for bacterial, microbial or mammalian cell culture expression, Thermo Fischer Scientif…
…
continue reading
1
[Solutions Spotlight] Special delivery: Lipid nanoparticles usher in new treatments
15:32
15:32
나중에 재생
나중에 재생
리스트
좋아요
좋아요
15:32
RNA-based vaccines have played a starring role in the ongoing COVID-19 pandemic and there is great potential for RNA to be applied to further indications. But nucleic acids are highly negatively charged and fragile and the right delivery systems are needed to protect RNA from degradation. One technology — lipid nanoparticles — has proven to enable …
…
continue reading
1
[Solutions Spotlight] Harnessing AI to improve workplace ergonomics
17:30
17:30
나중에 재생
나중에 재생
리스트
좋아요
좋아요
17:30
Poor ergonomics have been linked to a host of physical problems and can have an impact on workplace efficiency. Improving posture and physical habits has been linked to increased worker productivity and reduced errors. A reduction in injuries also saves money for companies, and helps businesses retain healthier and happier employees. However, many …
…
continue reading
Many inside and outside of the pharma industry think so. Now, one group is putting pressure on the FDA and Congress to move pharma away from animal modeling in drug development. Learn more about the White Coast Waste Project: https://www.whitecoatwaste.org/ Read the transcript: https://www.pharmamanufacturing.com/podcasts/off-script-a-pharma-manufa…
…
continue reading
When doctors administer treatments to patients, some amount of drug is often left behind in the vial. What happens next? It gets tossed. Now, Congress is taking a closer look at this issue and considering new policies aimed at reducing this kind of medical waste. Read the transcript: https://www.pharmamanufacturing.com/podcasts/off-script-a-pharma-…
…
continue reading
1
[Solutions Spotlight] Elevating quality inspection with AI
16:22
16:22
나중에 재생
나중에 재생
리스트
좋아요
좋아요
16:22
The importance of quality in pharma manufacturing can't be overstated. Fortunately, the industry has stepped up drug quality. While much of this can be attributed to better science and clearer guidance, technology improvements — like the application of AI to visual inspection equipment — have potential. Chief content director Karen Langhauser and G…
…
continue reading
If Biogen’s controversial aducanumab is approved, it could become the best-selling drug of all time — and it’s a drug that has only shown modest efficacy. Here’s more on why the Alzheimer’s pipeline is primed for such a remarkable situation. Read the transcript: https://www.pharmamanufacturing.com/podcasts/off-script-a-pharma-manufacturing-podcast/…
…
continue reading
The complex development and manufacturing processes needed to bring biologic drugs to market almost always translates into exorbitant prices, even after the drugs go off patent. Consequently, many areas of the world simply do not have access to the accepted standard of care. Chief content director Karen Langhauser sat down with the founders of Phyl…
…
continue reading
What has allowed the government to — for once — move at the speed of industry to help curb the pandemic? And will the FDA be able to maintain this pace once the pandemic winds down? We caught up a long-time regulatory expert to find out. Read the transcript.저자 Pharma Manufacturing
…
continue reading
Pharma stepped up to the plate this year to deliver vaccines in record time and desperately needed therapeutics. Will these historic achievements change the industry's reputation in the eyes of the public? Chief Content Director, Karen Langhauser, and Senior Editor, Meagan Parrish, take a look back at pharma's accomplishments — and stumbles — durin…
…
continue reading
The threat of superbugs hasn’t gone away and in many ways the pandemic has made this problem loom even larger. But a new organization called the AMR Action Fund is working to infuse needed dollars and resources into the dwindling pipeline for needed antibiotics. Read the full transcript저자 Pharma Manufacturing
…
continue reading
1
Reaching undecided vaxxers: Can pharma simultaneously advance vaccines and public trust
15:12
15:12
나중에 재생
나중에 재생
리스트
좋아요
좋아요
15:12
As several late-stage trials edge towards the finish line, skepticism surrounding vaccines continues to spread at a rate faster than the coronavirus itself — and drugmakers and health officials are scrambling to restore public trust. Pharma Manufacturing editors Karen Langhauser and Meagan Parrish discuss. Read the transcript here: https://bit.ly/3…
…
continue reading
1
[Solutions Spotlight] Pharma’s drive towards more sustainable packaging
13:34
13:34
나중에 재생
나중에 재생
리스트
좋아요
좋아요
13:34
Chief Content Director Karen Langhauser is joined by Richard Wood, Executive Director of Technical Solutions at Softbox Systems. Read the full transcript: https://bit.ly/2JaQOsQ Learn more: https://bit.ly/2G8oWo3저자 Pharma Manufacturing
…
continue reading
It's been called the biggest logistical challenge of all time. What does pharma and the government need to do to quickly and successfully deliver COVID-19 vaccines into the waiting arms of Americans? Senior editor, Meagan Parrish, chats with PwC's Omar Chane to find out. Read the full transcript here: https://bit.ly/3dJdhZs…
…
continue reading
Should America reshore more generic drug manufacturing? Will it really keep our supply chains safe from disruptions? For our September cover story, we took a deep dive into these questions to untangle the arguments around reshoring generic drug production. Find out why we walked away so obsessed with Rosemary Gibson and why Phlow Corp. might be the…
…
continue reading